Podlesak Dennisinsider trades
In SEC Form 4 filings, Podlesak Dennis is listed as Director of Syndax Pharmaceuticals Inc (SNDX). In the last 90 days, Podlesak Dennis sold $113.7K of Syndax Pharmaceuticals Inc (SNDX) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| SNDXSyndax Pharmaceuticals Inc | Director | 3 | Oct 30 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-30
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| SNDXSyndax Pharmaceuticals Inc | Oct 29 | Oct 30 | M | 8,000 | $11.81 | $94,480 | 247,763 | Yes | Form 4 |
| SNDXSyndax Pharmaceuticals Inc | Oct 29 | Oct 30 | S | 8,000 | $14.21 | Sale −$113,716 | 239,763 | Yes | Form 4 |
| SNDXSyndax Pharmaceuticals Inc | Oct 29 | Oct 30 | M · derivative | 8,000 | $11.81 | $94,480 | not reported | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.